Each edition highlights newly approved drugs by global and national agencies like the FDA and CDSCO, reports emerging adverse drug reactions, and explores recent scientific findings relevant to clinical practice. It also includes safety alerts such as Look-alike & Sound-alike (LASA) drug lists to prevent medication errors. With insights into evolving therapeutic options and comparative studies, Pharmabuzz serves as a valuable tool for healthcare professionals, students, and researchers aiming to stay informed and enhance patient care.